Two weeks after beginning olanzapine, Mr A noticed a new, pale tan, circular, scaly, mildly pruritic patch on the anterior of his right shoulder. Three weeks later, the dermatologic abnormality persisted, and dermatology was consulted. The dermatologist confirmed the diagnosis of a fungal dermatitis, tinea versicolor, and prescribed topical ketoconazole cream. The infection appeared to be improving after several weeks. The patient was discharged but was noncompliant with follow-up.
Discussion
Tinea versicolor, a superficial mycosis, is caused by several of the species of the genus, Malassezia (2). It occurs primarily in the tropics but is not rare in North America (2) . Other reported dermatologic adverse effects of olanzapine include vesiculobullous eruption, pruritus, and peripheral edema (3) . Although other antipsychotic agents have been associated with various dermatologic manifestations-including exanthems, pruritus, photosensitivity, angioedema, exfolliative dermatitis, and cellulitis-none except for ziprasidone have reported occurrences of fungal dermatitis linked with their use (3) . In this otherwise healthy patient with a negative history of fungal dermatitis, the infection arose 2 weeks after the initiation of pharmacotherapy, which supported the strength of this association. Resolution of the dermatitis after antifungal treatment, despite continuing olanzapine, makes it difficult to be certain about the causal nature of this relation. Nevertheless, physicians should be sensitive to the possibility of fungal dermatitis as a complication of olanzapine pharmacotherapy.
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Re: Canadian Psychiatric Inpatient Religious Commitment
Dear Editor:
Dr Watters is somewhat disingenuous in using his "critique" (1) of the study by Baetz and others (2) to advocate his well-known view of "religion as the most destructive of human inventions." The search for finding meaning and guidance about life and death has been around for thousands of years and can hardly be described as an "invention." It has been expressed in what we choose to call "religion" in many ways that have changed over time but are present in all cultures. These philosophical considerations, however, were not the issue in the paper by Baetz and others.
Their study is welcome. It attempts to bridge the gap between 2 aspects of human behaviour that are frequently seen in isolation: psychopathology and religious observance. They also admit to the limitations of their investigation. One could add that answers to 3 questions on a Gallup Poll (3) can only provide a simplistic view of an individual's belief system. Moreover, religious commitment seemed restricted to adherence to the Christian religion, perhaps inevitable in the demographic distribution of the study population. Similarly, length of stay in hospital is, at best, a rough indication of clinical status.
Nevertheless, the paper by Baetz and others is a welcome start, and a more detailed investigation into the relation between overt psychopathology and religious beliefs and practices could lead to useful dialogue and enhancement of our therapeutic armamentarium.
